Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshihiro Ide

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Clinical Case Reports|July 11, 2024
Fulminant demyelinating disease of the central nervous system effectively treated with a combination of decompressive craniectomy and immunotherapy: A case report and literature reviewToshihiro Ide, Ryo Ebashi, Makoto Eriguchi, et al.
Rinsho Shinkeigaku = Clinical Neurology|May 7, 2016
Pre-critical MRI findings of an Alzheimer's disease patient with pathologically proven cerebral amyloid angiopathy related lobar hemorrhageToshihiro Nonaka, Yusuke Yakushiji, Toshihiro Ide, et al.
Rinsho Shinkeigaku = Clinical Neurology|December 20, 2021
[Central nervous system involvement of graft versus host disease after allogeneic hematopoietic stem cell transplantation for adult T cell leukemia]Toshihiro Ide, Kotaro Iida, Hiroo Katsuya, et al.
Frontiers in Neurology|March 30, 2026
Real-world outcomes after switching from standard therapy to efgartigimod in five patients with chronic inflammatory demyelinating polyradiculoneuropathy: a case series study in JapanTatsuya Imai, Kenichi Irie, Shinichiro Mori, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 26, 2025
Typical distribution of hypertensive cerebral microbleed: a matched case-control study using primary aldosteronismShuhei Ikeda, Yusuke Yakushiji, Kotaro Iida, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 12, 2026
Significance of aberrant nerve conduction in hereditary transthyretin amyloidosisToshihiro Ide, Masaaki Yoshikawa, Kohei Suzuyama, et al.
Internal Medicine (Tokyo, Japan)|March 18, 2026
Real-World Application of Subcutaneous Efgartigimod in Chronic Inflammatory Demyelinating PolyradiculoneuropathyMasaaki Yoshikawa, Yuta Goto, Masaomi Tsutsumi, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 6, 2023
Associations for progression of cerebral small vessel disease burden in healthy adults: the Kashima scan studyToshihiro Ide, Yusuke Yakushiji, Kohei Suzuyama, et al.
Internal Medicine (Tokyo, Japan)|November 19, 2025
Hereditary Neuropathy with Liability to Pressure Palsies Unmasked by Polatuzumab Vedotin-containing ChemotherapyTakeru Kawanami, Masaaki Yoshikawa, Yuta Goto, et al.
Internal Medicine (Tokyo, Japan)|August 7, 2024
Efgartigimod Successfully Ameliorated Acute Exacerbation of Myasthenia Gravis with Anti-muscle-specific Kinase AntibodiesKoya Tanaka, Masaaki Yoshikawa, Yukako Inoue, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Clinical Case Reports|July 11, 2024
Fulminant demyelinating disease of the central nervous system effectively treated with a combination of decompressive craniectomy and immunotherapy: A case report and literature reviewToshihiro Ide, Ryo Ebashi, Makoto Eriguchi, et al.
Rinsho Shinkeigaku = Clinical Neurology|May 7, 2016
Pre-critical MRI findings of an Alzheimer's disease patient with pathologically proven cerebral amyloid angiopathy related lobar hemorrhageToshihiro Nonaka, Yusuke Yakushiji, Toshihiro Ide, et al.
Rinsho Shinkeigaku = Clinical Neurology|December 20, 2021
[Central nervous system involvement of graft versus host disease after allogeneic hematopoietic stem cell transplantation for adult T cell leukemia]Toshihiro Ide, Kotaro Iida, Hiroo Katsuya, et al.
Frontiers in Neurology|March 30, 2026
Real-world outcomes after switching from standard therapy to efgartigimod in five patients with chronic inflammatory demyelinating polyradiculoneuropathy: a case series study in JapanTatsuya Imai, Kenichi Irie, Shinichiro Mori, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 26, 2025
Typical distribution of hypertensive cerebral microbleed: a matched case-control study using primary aldosteronismShuhei Ikeda, Yusuke Yakushiji, Kotaro Iida, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 12, 2026
Significance of aberrant nerve conduction in hereditary transthyretin amyloidosisToshihiro Ide, Masaaki Yoshikawa, Kohei Suzuyama, et al.
Internal Medicine (Tokyo, Japan)|March 18, 2026
Real-World Application of Subcutaneous Efgartigimod in Chronic Inflammatory Demyelinating PolyradiculoneuropathyMasaaki Yoshikawa, Yuta Goto, Masaomi Tsutsumi, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 6, 2023
Associations for progression of cerebral small vessel disease burden in healthy adults: the Kashima scan studyToshihiro Ide, Yusuke Yakushiji, Kohei Suzuyama, et al.
Internal Medicine (Tokyo, Japan)|November 19, 2025
Hereditary Neuropathy with Liability to Pressure Palsies Unmasked by Polatuzumab Vedotin-containing ChemotherapyTakeru Kawanami, Masaaki Yoshikawa, Yuta Goto, et al.
Internal Medicine (Tokyo, Japan)|August 7, 2024
Efgartigimod Successfully Ameliorated Acute Exacerbation of Myasthenia Gravis with Anti-muscle-specific Kinase AntibodiesKoya Tanaka, Masaaki Yoshikawa, Yukako Inoue, et al.
Pageof 5